Want to see NAMS full AI Analyst Report?
NewAmsterdam Pharma Company (NAMS) Ownership Overview
6.04% Insiders
21.96% Mutual Funds
19.36% Other Institutional Investors
1.82% ETFs
50.81% Public Companies and
Individual Investors
The ownership structure of NewAmsterdam Pharma Company (NAMS) stock is a mix of institutional, retail, and individual investors. Approximately 43.15% of the company’s stock is owned by Institutional Investors, 6.04% is owned by Insiders, and 50.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 09, 2026 | xxxxxxxxxxxxx | $40512 | |
Aug 25, 2026 | xxxxxxxxxxxxx | $3363750 | |
Jul 22, 2026 | xxxxxxxxxxxxx | $3185656 | |
Jun 24, 2026 | xxxxxxxxxxxxx | $1208159 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $7593732 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $25501852 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $110745810 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,550,191 | Institution | 7.99% | 217,744,355 | |
| 8,396,080 | Institution | 7.02% | 191,430,624 | |
| 6,829,524 | Insider | 5.71% | 155,713,147 | |
| 4,264,789 | Institution | 3.57% | 97,237,189 | |
| 4,203,567 | Institution | 3.52% | 95,841,328 | |
| 3,425,823 | Institution | 2.87% | 78,108,764 | |
| 3,267,802 | Institution | 2.73% | 74,505,886 | |
| 3,070,146 | Institution | 2.57% | 69,999,329 | |
| 1,564,648 | Institution | 1.31% | 35,673,974 | |
| 1,463,192 | Institution | 1.22% | 33,360,778 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,396,080 | Institution | 7.02% | 191,430,624 | |
| 3,425,823 | Institution | 2.87% | 78,108,764 | |
| 1,564,648 | Institution | 1.31% | 35,673,974 | |
| 1,463,192 | Institution | 1.22% | 33,360,778 | |
| 1,232,500 | Institution | 1.03% | 28,101,000 | |
| 1,040,690 | Institution | 0.87% | 23,727,732 | |
| 957,477 | Institution | 0.80% | 21,830,476 | |
| 936,400 | Institution | 0.78% | 21,349,920 | |
| 534,102 | Institution | 0.45% | 12,177,526 | |
| 497,509 | Institution | 0.42% | 11,343,205 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 720,210 | Institution | 0.60% | 15,743,791 | |
| 612,706 | Institution | 0.51% | 13,969,697 | |
| 183,081 | Institution | 0.15% | 5,087,821 | |
| 161,062 | Institution | 0.13% | 3,672,214 | |
| 93,874 | Institution | 0.08% | 2,052,086 | |
| 51,311 | Institution | 0.04% | 1,169,891 | |
| 49,856 | Institution | 0.04% | 1,385,498 | |
| 42,895 | Institution | 0.04% | 2,061,726 | |
| 34,620 | Institution | 0.03% | 756,793 | |
| 31,864 | Institution | 0.03% | 696,547 |
FAQ
Who Owns NewAmsterdam Pharma Company (NAMS)?
According to the latest TipRanks data, approximately 19.36% of the company's stock is held by institutional investors, 6.04% is held by insiders, and 50.81% is held by retail investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.36% of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.81% of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors.
Who owns the most shares of NewAmsterdam Pharma Company (NAMS)?
Peter Kolchinsky owns the most shares of NewAmsterdam Pharma Company (NAMS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.